SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-15-003053
Filing Date
2015-04-29
Accepted
2015-04-29 16:41:22
Documents
3
Period of Report
2015-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q22015form8-k42915.htm 8-K 37313
2 EXHIBIT 99.1 q22015pressreleaseleiden42.htm EX-99.1 12384
3 logo.jpg GRAPHIC 12685
  Complete submission text file 0001628280-15-003053.txt   68545
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 15813380
SIC: 2834 Pharmaceutical Preparations